n-methyl-3,4-methylenedioxyamphetamine has been researched along with Somatoform Disorders in 3 studies
N-Methyl-3,4-methylenedioxyamphetamine: An N-substituted amphetamine analog. It is a widely abused drug classified as a hallucinogen and causes marked, long-lasting changes in brain serotonergic systems. It is commonly referred to as MDMA or ecstasy.
3,4-methylenedioxymethamphetamine : A member of the class of benzodioxoles that is 1,3-benzodioxole substituted by a 2-(methylamino)propyl group at position 5.
Somatoform Disorders: Disorders having the presence of physical symptoms that suggest a general medical condition but that are not fully explained by another medical condition, by the direct effects of a substance, or by another mental disorder. The MEDICALLY UNEXPLAINED SYMPTOMS must cause clinically significant distress or impairment in social, occupational, or other areas of functioning. In contrast to FACTITIOUS DISORDERS and MALINGERING, the physical symptoms are not under voluntary control. (APA, DSM-V)
| Excerpt | Relevance | Reference |
|---|---|---|
| " Problematic ecstasy users reported significantly higher levels of ecstasy use, including lifetime consumption, average dosage and binge consumption compared to non-problematic ecstasy users." | 1.33 | Problematic versus non-problematic ecstasy/MDMA use: the influence of drug usage patterns and pre-existing psychiatric factors. ( Parrott, AC; Soar, K; Turner, JJ, 2006) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Senon, JL | 1 |
| Lafay, N | 1 |
| Padet, N | 1 |
| Milani, RM | 1 |
| Parrott, AC | 2 |
| Turner, JJ | 2 |
| Fox, HC | 1 |
| Soar, K | 1 |
1 review available for n-methyl-3,4-methylenedioxyamphetamine and Somatoform Disorders
| Article | Year |
|---|---|
[Medication-induced psychoses].
Topics: Cannabis; Hallucinogens; Humans; N-Methyl-3,4-methylenedioxyamphetamine; Psychoses, Substance-Induce | 2003 |
2 other studies available for n-methyl-3,4-methylenedioxyamphetamine and Somatoform Disorders
| Article | Year |
|---|---|
Gender differences in self-reported anxiety, depression, and somatization among ecstasy/MDMA polydrug users, alcohol/tobacco users, and nondrug users.
Topics: Adult; Amphetamine-Related Disorders; Analysis of Variance; Anxiety Disorders; Depressive Disorder; | 2004 |
Problematic versus non-problematic ecstasy/MDMA use: the influence of drug usage patterns and pre-existing psychiatric factors.
Topics: Adolescent; Adult; Amphetamine-Related Disorders; Anxiety Disorders; Comorbidity; Depressive Disorde | 2006 |